Gamida Cell Ltd.

OTCPK:GMDA.Q Stok Raporu

Piyasa değeri: US$2.6m

Gamida Cell Yönetim

Yönetim kriter kontrolleri 2/4

Gamida Cell's CEO is Abbey Jenkins, appointed in Sep 2022, has a tenure of 1.67 years. total yearly compensation is $1.36M, comprised of 41.8% salary and 58.2% bonuses, including company stock and options. directly owns 0.38% of the company’s shares, worth $9.89K. The average tenure of the management team and the board of directors is 2.9 years and 4.9 years respectively.

Anahtar bilgiler

Abbey Jenkins

İcra Kurulu Başkanı

US$1.4m

Toplam tazminat

CEO maaş yüzdesi41.8%
CEO görev süresi1.7yrs
CEO sahipliği0.4%
Yönetim ortalama görev süresi2.9yrs
Yönetim Kurulu ortalama görev süresi4.9yrs

Son yönetim güncellemeleri

Recent updates

Gamida Cell shares slide after stock offering

Sep 27

Gamida appoints Emergent’s former head of vaccines as new CEO

Sep 19

Gamida Cell Q2 2022 Earnings Preview

Aug 12

Gamida stock rises 13% as FDA grants priority review to stem cell therapy omidubicel

Aug 01

Does Gamida Cell (NASDAQ:GMDA) Have A Healthy Balance Sheet?

Feb 23
Does Gamida Cell (NASDAQ:GMDA) Have A Healthy Balance Sheet?

Gamida Cell: Recapping A Tough Year

Nov 02

Gamida Cell (NASDAQ:GMDA) Has Debt But No Earnings; Should You Worry?

Nov 02
Gamida Cell (NASDAQ:GMDA) Has Debt But No Earnings; Should You Worry?

CEO Tazminat Analizi

Abbey Jenkins'un ücretlendirmesi Gamida Cell'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2024n/an/a

-US$62m

Dec 31 2023US$1mUS$571k

-US$63m

Sep 30 2023n/an/a

-US$77m

Jun 30 2023n/an/a

-US$93m

Mar 31 2023n/an/a

-US$80m

Dec 31 2022US$707kUS$157k

-US$79m

Tazminat ve Piyasa: Abbey's total compensation ($USD1.36M) is above average for companies of similar size in the US market ($USD661.07K).

Tazminat ve Kazançlar: Abbey's compensation has increased whilst the company is unprofitable.

CEO

Abbey Jenkins (47 yo)

1.7yrs

Görev süresi

US$1,364,308

Tazminat

Ms. Abigail L. Jenkins, M.S. also known as Abbey, serves as a Director at XORTX Therapeutics Inc. since April 08, 2024. She is Independent Director of Aquestive Therapeutics, Inc. from April 1, 2024. She i...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Abigail Jenkins
President1.7yrsUS$1.36m0.38%
$ 9.9k
Mary Coelho
Chief Financial Officerless than a yearUS$1.06mVeri yok
Ronit Simantov
Chief Medical Officer & Chief Scientific Officer6.8yrsUS$1.34m0.33%
$ 8.7k
Linda Stamler
Vice President of Marketing & Account Management3.3yrsVeri yokVeri yok
Penny Bushell
Chief Human Resource Officer1.5yrsVeri yokVeri yok
Naftali Brikashvili
Senior Vice President Finance & Operationsno dataVeri yokVeri yok
Tracey Lodie
Scientific Advisor & Consultant2.8yrsVeri yokVeri yok
Vladimir Melnikov
Senior Vice President of Global Operations & Manufacturing2.9yrsVeri yokVeri yok
Heather DiVecchia
Chief of Staffno dataVeri yokVeri yok
Rocio Manghani
Senior Vice President of Market Access3.5yrsVeri yokVeri yok
Kelly Randis
Head of Global Information Technologyno dataVeri yokVeri yok

2.9yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: GMDA.Q's management team is considered experienced (2.9 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Abigail Jenkins
President1.7yrsUS$1.36m0.38%
$ 9.9k
Kenneth Moch
Independent Director7.8yrsUS$179.77k0.10%
$ 2.7k
Stephen Wills
Independent Director4.9yrsUS$213.10k0.12%
$ 3.2k
Julian Adams
Director7.8yrsUS$865.34k0.89%
$ 23.4k
Shawn Tomasello
Independent Chairwoman4.9yrsUS$209.17k0.11%
$ 2.8k
Ivan Borrello
Independent Director1.9yrsUS$161.86k0.070%
$ 1.8k

4.9yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: GMDA.Q's board of directors are considered experienced (4.9 years average tenure).